UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2012

 


 

Commission File Number: 001-34225

 


 

VIMICRO INTERNATIONAL CORPORATION

 

15/F Shining Tower
No. 35 Xueyuan Road, Haidian District
Beijing 100191, People’s Republic of China
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F  x

 

Form 40-F  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

This Form 6-K is being incorporated by reference into the registrant’s Registration Statement on Form S-3 (File No. 333-166948), filed with the Securities and Exchange Commission on May 19, 2010.

 

 

 



 

Third-Quarter 2012 Results

 

Vimicro International Corporation (“Vimicro” or the “Company”) reports its unaudited financial results for the third quarter ended September 30, 2012 .

 

Net revenue in the third quarter of 2012 was $21.7 million, as compared to net revenue from continuing operations of $19.5 million in the second quarter and $18.9 million from continuing operations in the year-ago quarter. (Results for the third quarter of 201 1 and the second and third quarters of 2012 have been adjusted to reflect the divestiture of certain business lines .) The 14.9% year-over-year revenue increase was due to an increase in sales in both product lines, reflecting more managerial and operating resources allocated to our continuing operations after the business disposals.

 

Gross profit in the third quarter was $8.3 million, as compared with $6.0 million in the year-ago quarter.  The gross margin in the third quarter was 38.0%, as compared with 31. 8 % in the year-ago quarter and 36.5% in the second quarter, reflecting higher gross margin yielded from some new products.

 

Operating expenses in the third quarter were $6.8 million, as compared to $11.3 million in the year-ago quarter.  Operating expenses decreased year-over-year, due to the Company’s divestiture of under-performing businesses and an increase in focus on its two continuing business lines. The Company recorded an operating income of $1.5 million, as compared to a loss of $5.3 million in the year-ago quarter.

 

Vimicro remained profitable on a non-GAAP basis in the third quarter, and non-GAAP net income from continuing operations attributable to Vimicro International Corporation was $ 2.9 million , or approximately $0.09 per ADS on a diluted basis , as compared to a non-GAAP net loss from continuing operations attributable to Vimicro of $ 1.7 million, or $0.05 per ADS in the year-ago quarter.  The non-GAAP net income attributable to Vimicro International Corporation excludes $0.4 million of non-cash, share-based compensation.  In the third quarter, Vimicro recorded a net income attributable to Vimicro of $2.9 million, or $0. 10 per ADS on a diluted basis, as compared to a loss of $ 5 .3 million, or $0. 14 per ADS in the year-ago quarter .

 

As of September 30, 2012, the Company had cash and cash equivalents of approximately $33.2 million and restricted cash of $5.2 million, totaling $38.4 million. Total current assets were approximately $ 91.8 million. Vimicro had a working capital of approximately $ 64.7 million, and long-term bank loans of $4.7 million on its balance sheet, as of September 30, 2012.

 

2



 

Non-GAAP Measures

 

To supplement the consolidated financial statements presented in accordance with GAAP, Vimicro uses non-GAAP measures of non-GAAP income/(loss) from operations, non-GAAP net income/(loss) attributed to Vimicro International Corporation and non-GAAP diluted net income /(loss) from continuing operations per ADS, which are adjusted from the most directly comparable financial measures calculated and presented in accordance with GAAP to exclude amortization of share-based compensation expense. These non-GAAP financial measures are provided to enhance investors’ overall understanding of the Company’s financial performance as they exclude share-based expenses that are not expected to result in future cash payments. The non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to GAAP results. A limitation of using these non-GAAP financial measures is that these non-GAAP measures exclude share-based compensation charges that have been and will continue to be significant recurring expenses in our business for the foreseeable future. We compensate for these limitations by providing the relevant disclosure of our share-based compensation charges in our reconciliations to the GAAP measures. For more information on the non-GAAP financial measures, please see the tables captioned “Reconciliation of non- GAAP results of operations measures to the nearest comparable GAAP measures” set forth at the end of this release.

 

Vimicro believes that both management and investors benefit from referring to these non-GAAP measures in assessing the performance of Vimicro’s liquidity and when planning and forecasting future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to Vimicro’s historical liquidity. Vimicro computes its non-GAAP financial measures using the same consistent method from quarter to quarter. The accompanying tables have more details on the GAAP financial measures that are most comparable to non-GAAP financial measures and the related reconciliations between financial measures.

 

Currency Translation

 

This announcement contains translations of certain RMB amounts into U.S. dollars. Unless otherwise noted, all translations from RMB to U.S. dollars are based on the applicable exchange rates quoted by the Bank of China, which was RMB 6.3410 to $1.00 on September 28, 2012.

 

3



 

Vimicro International Corporation

Consolidated Balance Sheets

(Amounts expressed in thousands of U.S. dollars, except number of shares data)

 

 

 

9/30/2012

 

12/31/2011

 

 

 

(unaudited)

 

(audited)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

33,192

 

49,227

 

Restricted cash

 

5,201

 

3,520

 

Accounts and notes receivable, net of provision for doubtful accounts of $2,070 and $1,822 as of September 30, 2012 and December 31, 2011, respectively

 

23,126

 

17,895

 

Amounts due from related party

 

7,580

 

4,831

 

Inventories

 

12,886

 

18,734

 

Prepayments and other current assets, net of provision for doubtful accounts of $305 and $162 as of September 30, 2012 and December 31, 2011, respectively

 

2,994

 

4,057

 

Asset held-for-sale

 

6,474

 

0

 

Deferred tax assets

 

357

 

356

 

Total current assets

 

91,810

 

98,620

 

Investment in an unconsolidated affiliate

 

5,612

 

1,520

 

Property, equipment and software, net

 

16,337

 

14,266

 

Land use rights

 

14,675

 

21,488

 

Deferred tax assets-non current

 

112

 

112

 

Other assets

 

1,535

 

1,291

 

Total assets

 

130,081

 

137,297

 

 

 

 

 

 

 

Liabilities and Equity

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

Accounts payable

 

5,111

 

9,280

 

Notes payable

 

0

 

1,013

 

Amounts due to related party

 

672

 

963

 

Taxes payable

 

2,835

 

1,209

 

Advances from customers

 

230

 

1,916

 

Accrued expenses and other current liabilities

 

8,436

 

8,333

 

Deferred government grant

 

9,841

 

5,910

 

Total current liabilities

 

27,125

 

28,624

 

Non-current liabilities:

 

 

 

 

 

Deferred tax liabilities

 

33

 

33

 

Product warranty

 

424

 

300

 

Long-term bank loan

 

4,731

 

0

 

Total liabilities

 

32,313

 

28,957

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

Ordinary shares,$0.0001 par value, 500,000,000 shares authorized, 118,231,636 and 139,953,296 shares issued and outstanding as of September 30, 2012 and December 31, 2011, respectively

 

15

 

15

 

Additional paid-in capital

 

160,612

 

158,879

 

Treasury stock

 

(13,254

)

(6,490

)

Accumulated other comprehensive income

 

12,695

 

12,850

 

Accumulated deficit

 

(83,704

)

(82,630

)

Statutory reserve

 

2,782

 

2,782

 

Total equity attributable to Vimicro International Corporation

 

79,146

 

85,406

 

Non-controlling interest

 

18,622

 

22,934

 

Total equity

 

97,768

 

108,340

 

 

 

 

 

 

 

Total liabilities and equity

 

130,081

 

137,297

 

 

4



 

Vimicro International Corporation

Consolidated Statement Of Comprehensive Income/ (loss)

(Amounts expressed in thousands of U.S. dollars, except number of shares and per share data)

 

 

 

2012 Q3

 

2012 Q2

 

2011 Q3

 

 

 

(unaudited)

 

(unaudited)

 

(unaudited)

 

 

 

 

 

 

 

 

 

Net revenue

 

21,748

 

19,519

 

18,921

 

 

 

 

 

 

 

 

 

Cost of revenue

 

(13,490

)

(12,404

)

(12,905

)

 

 

 

 

 

 

 

 

Gross profit

 

8,258

 

7,115

 

6,016

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Research and development, net

 

(1,840

)

(2,842

)

(5,308

)

Selling and marketing

 

(2,484

)

(2,159

)

(3,261

)

General and administrative

 

(2,452

)

(3,047

)

(2,758

)

Total operating expenses

 

(6,776

)

(8,048

)

(11,327

)

Income/(loss) from operations

 

1,482

 

(933

)

(5,311

)

 

 

 

 

 

 

 

 

Other income:

 

 

 

 

 

 

 

Interest income

 

3

 

125

 

210

 

Foreign exchange gain/(loss), net

 

(87

)

(159

)

617

 

Others, net

 

1

 

1

 

5

 

 

 

 

 

 

 

 

 

Income/ (loss) before income taxes and share of profit/ (loss) of an unconsolidated affiliates

 

1,399

 

(966

)

(4,479

)

 

 

 

 

 

 

 

 

Income tax (expense)/ beneifit

 

(227

)

(175

)

37

 

 

 

 

 

 

 

 

 

Net income/ (loss) before share of profit/ (loss) of an unconsolidated affiliates

 

1,172

 

(1,141

)

(4,442

)

 

 

 

 

 

 

 

 

Net income/ (loss) from continuing operations

 

1,172

 

(1,141

)

(4,442

)

 

 

 

 

 

 

 

 

Income/ (loss) from discontinued operations, net of income tax

 

494

 

(699

)

(2,920

)

 

 

 

 

 

 

 

 

Net income/ (loss)

 

1,666

 

(1,840

)

(7,362

)

 

 

 

 

 

 

 

 

Loss attributable to non-controlling interest

 

(1,277

)

(1,497

)

(2,096

)

 

 

 

 

 

 

 

 

Income/ (loss) attributed to Vimicro International Corporation

 

2,943

 

(343

)

(5,266

)

 

 

 

 

 

 

 

 

Income/ (loss) per share

 

 

 

 

 

 

 

continuing operations

 

 

 

 

 

 

 

Basic

 

0.02

 

0.00

 

(0.02

)

Diluted

 

0.02

 

0.00

 

(0.02

)

discontinued operations

 

 

 

 

 

 

 

Basic

 

0.00

 

0.00

 

(0.02

)

Diluted

 

0.00

 

0.00

 

(0.02

)

Income/ (loss) per share

 

 

 

 

 

 

 

Basic

 

0.02

 

(0.00

)

(0.04

)

Diluted

 

0.02

 

(0.00

)

(0.04

)

 

 

 

 

 

 

 

 

Income/ (loss) per ADS

 

 

 

 

 

 

 

continuing operations

 

 

 

 

 

 

 

Basic

 

0.08

 

0.01

 

(0.06

)

Diluted

 

0.08

 

0.01

 

(0.06

)

discontinued operations

 

 

 

 

 

 

 

Basic

 

0.02

 

(0.02

)

(0.08

)

Diluted

 

0.02

 

(0.02

)

(0.08

)

Income/ (loss) per ADS

 

 

 

 

 

 

 

Basic

 

0.10

 

(0.01

)

(0.14

)

Diluted

 

0.10

 

(0.01

)

(0.14

)

 

 

 

 

 

 

 

 

Weighted average number of ordinary shares outstanding

 

 

 

 

 

 

 

Basic

 

118,625,664

 

121,877,701

 

146,852,718

 

Diluted

 

121,700,752

 

121,877,701

 

146,852,718

 

Weighted average number of ADS outstanding

 

 

 

 

 

 

 

Basic

 

29,656,416

 

30,469,425

 

36,713,179

 

Diluted

 

30,425,188

 

30,469,425

 

36,713,179

 

 

 

 

 

 

 

 

 

Other comprehensive income/ (loss):

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

(254

)

(175

)

1,176

 

 

 

 

 

 

 

 

 

Comprehensive income/ (loss)

 

1,412

 

(2,015

)

(6,186

)

Comprehensive income/ (loss) attributable to non-controlling interest

 

(1,535

)

(1,498

)

(1,571

)

Comprehensive income/ (loss) attributable to Vimicro International Corporation

 

2,947

 

(517

)

(4,615

)

 

Components of share-based compensation expenses are included in the following expense captions:

 

 

 

 

 

 

 

R&D

 

(220

)

(462

)

(165

)

S&M

 

(40

)

(50

)

(15

)

G&A

 

(167

)

(560

)

(450

)

Total

 

(427

)

(1,072

)

(630

)

 

5



 

Reconciliations of non-GAAP results of operations measures to the nearest comparable GAAP measures (*)

(Amounts expressed in thousands of U.S. dollars, except per share data,unaudited)

 

 

 

Three months ended

 

Three months ended

 

Three months ended

 

 

 

September 30,

 

June 30,

 

September 30,

 

 

 

2012

 

2012

 

2011

 

 

 

GAAP

 

 

 

Non-
GAAP

 

GAAP

 

 

 

Non-
GAAP

 

GAAP

 

 

 

Non-
GAAP

 

 

 

Result

 

Adjustment

 

Results

 

Result

 

Adjustment

 

Results

 

Result

 

Adjustment

 

Results

 

Income/(loss) from continuing operations

 

1,482

 

427

 

1,909

 

(933

)

1,072

 

139

 

(5,311

)

630

 

(4,681

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) attributed to Vimicro International Corporation

 

2,943

 

427

 

3,370

 

(343

)

1,072

 

729

 

(5,266

)

630

 

(4,636

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) from continuing operations per ADS(**)

 

0.08

 

0.01

 

0.09

 

0.01

 

0.04

 

0.05

 

(0.06

)

0.01

 

(0.05

)

 


(*) The adjustment is to exclude non-cash share-based compensation for employees and non-employees.

(**) Loss per ADS refers to continuing operations

 

6



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

VIMICRO INTERNATIONAL CORPORATION

 

 

 

 

By:

/s/ John Zhonghan Deng

 

Name:

John Zhonghan Deng

 

Title:

Chairman and Chief Executive Officer

 

 

Date: November 13, 2012

 

7


(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 (MM) 차트를 더 보려면 여기를 클릭.
(MM) (NASDAQ:VIMC)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 (MM) 차트를 더 보려면 여기를 클릭.